1. Quality of life, resource utilisation and health economics assessment in advanced neuroendocrine tumours: a systematic review. (29th July 2013) Authors: Chau, I.; Casciano, R.; Willet, J.; Wang, X.; Yao, J.C. Journal: European journal of cancer care Issue: Volume 22:Number 6(2013:Nov.) Page Start: 714 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EXCELLENT OUTCOMES USING RITUXIMAB, GEMCITABINE, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISOLONE (R‐GCVP) IN PATIENTS WITH DLBCL AND CARDIAC COMORBIDITIES. (12th June 2019) Authors: Michalarea, V.; Low, R.; Kirkwood, A.A.; Harrington, P.; Yadollahi, S.; Djebbari, F.; Gleeson, M.; Cwynarski, K.; Lambert, J.; Chau, I.; Wrench, D.; Eyre, T.A.; Davies, A.; Ardeshna, K.M.; Cunningham, D.; Fields, P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. COMPARISON OF OUTCOMES BETWEEN PATIENTS WITH MYC REARRANGED DLBCL AND DOUBLE/ TRIPLE HIT HIGH‐GRADE B CELL LYMPHOMA: A PAN‐LONDON RETROSPECTIVE REVIEW. (12th June 2019) Authors: El‐Sharkawi, D.; Sharma, S.; Cook, L.; Hanley, B.; Johnston, R.; Arasaretnam, A.; Lazana, I.; Greaves, P.; Parkinson, A.; Peng, Y.; Kassam, S.; Peacock, V.; Kaczmarski, R.; Bower, M.; Cheung, B.; De Lord, C.; Cross, M.; Vroobel, K.; Wotherspoon, A.; Aldridge, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CHOP VERSUS GEM‐P IN THE FIRST‐LINE TREATMENT OF T‐CELL LYMPHOMA (PTCL): INITIAL RESULTS OF THE UK NRCI PHASE II RANDOMISED CHEMO‐T TRIAL. (June 2017) Authors: Gleeson, M.; Peckitt, C.; To, Y.M.; Edwards, L.; Chau, I.; Johnson, P.; Ardeshna, K.M.; Wotherspoon, A.; Attygalle, A.; Begum, R.; Chua, S.; Zerizer, I.; Hawkes, E.A.; Macheta, M.P.; Collins, G.P.; Radford, J.A.; Forbes, A.; Hart, A.; Montoto, S.; McKay, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. TAK‐659, AN INVESTIGATIONAL REVERSIBLE DUAL SYK/FLT‐3 INHIBITOR, IN PATIENTS WITH LYMPHOMA: UPDATED RESULTS FROM DOSE‐ESCALATION AND EXPANSION COHORTS OF a PHASE 1 STUDY. (June 2017) Authors: Kaplan, J.; Gordon, L.; Infante, J.; Popat, R.; Rambaldi, A.; Madan, S.; Patel, M.R.; Gritti, G.; El‐Sharkawi, D.; Chau, I.; Radford, J.; Perez De Oteyza, J.; Zinzani, P.; Iyer, S.; Faucette, S.; Sheldon‐Waniga, E.; Stumpo, K.; Shou, Y.; Carpio, C.; Bosch, F. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THE ROLE OF 18F FDG‐PET/CT IN PERIPHERAL T‐CELL LYMPHOMA (PTCL): INITIAL RESULTS OF THE UK NCRI MULTICENTRE PHASE II RANDOMISED CHEMO‐T TRIAL PET/CT SUBSTUDY. (June 2017) Authors: Gleeson, M.; Peckitt, C.; Cunningham, D.; To, Y.M.; Edwards, L.; Chau, I.; Johnson, P.; Ardeshna, K.M.; Wotherspoon, A.; Attygalle, A.; Begum, R.; Zerizer, I.; Hawkes, E.A.; Macheta, M.P.; Collins, G.P.; Radford, J.A.; Forbes, A.; Hart, A.; Montoto, S.; McKay, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Chronic lymphocytic leukaemia and Richter's transformation: multimodal review and new imaging paradigms. Issue 11 (November 2021) Authors: Musanhu, E.; Sharma, R.K.; Attygalle, A.; Wotherspoon, A.; Chau, I.; Cunningham, D.; Dearden, C.; El-Sharkawi, D.; Iyengar, S.; Sharma, B. Journal: Clinical radiology Issue: Volume 76:Issue 11(2021) Page Start: 789 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 2343 Quality of life (QoL) as a prognostic factor for survival in previously treated advanced gastric or gastroesophageal junction (GEJ) cancer: Analysis of pooled data from two phase 3 studies (REGARD and RAINBOW). (September 2015) Authors: Chau, I.; Fuchs, C.; Muro, K.; Tomasek, J.; Van Cutsem, E.; Cho, J.Y.; Oh, S.C.; Safran, H.; Bodoky, G.; Shimada, Y.; Dumitru, F.; Passalacqua, R.; Ohtsu, A.; Hsu, Y.; Liepa, A.; Chandrawansa, K.; Emig, M.; Ferry, D.; Wilke, H.; Al-Batran, S.E. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 2188 Prognostic role of the LCS-6 KRAS variant in locally advanced rectal cancer: Results of the EXPERT-C trial. (September 2015) Authors: Sclafani, F.; Chau, I.; Cunningham, D.; Peckitt, C.; Lampis, A.; Hahne, J.C.; Braconi, C.; Tabernero, J.; Glimelius, B.; Cervantes, A.; Begum, R.; Castro, D. Gonzalez De; Hulkki Wilson, S.; Eltahir, Z.; Wotherspoon, A.; Tait, D.; Brown, G.; Oates, J.; Valeri, N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 2337 Ramucirumab (RAM) as a second-line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib in the randomized phase III REACH study: Analysis of alpha-fetoprotein (AFP) kinetics during treatment. (September 2015) Authors: Chau, I.; Park, J.O.; Ryoo, B.Y.; Yen, C.J.; Poon, R.; Pastorelli, D.; Blanc, J.F.; Kudo, M.; Pfiffer, T.F.; Hatano, E.; Chung, H.C.; Kubackova, K.; Phelip, J.M.; Brandi, G.; Ohkawa, S.; Li, C.P.; Okusaka, T.; Yang, L.; Abada, P.; Zhu, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗